… Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child
transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010 May …

… for enrolled patients, except that prescription of new antiretroviral drugs was discouraged …
Highly active antiretroviral therapy was defined as prescription of at least three antiretroviral …

… use of highly active antiretroviral therapy (HAART) for treating HIV infection. HAART — a …
and mortality and is a highly cost-effective medical intervention.The goal of combination …

… highly active antiretroviral therapy (HAART) use in Africa to identify lessons learned. With
the World Health Organization (WHO) guidelines used as a frame of reference, we assessed …

… Abstract: Highly active antiretroviral therapy (HAART) dramatically changed the course of
HIV infection. Currently, this therapy involves the use of agents from at least two distinct classes …

… Recent increases in access to highly active antiretroviral therapy (HAART) have made the
management of drug toxicities an increasingly crucial component of human immunodeficiency …

… the relative potency of highly active antiretroviral therapy may be … benefits of highly active
antiretroviral therapy (HAART) in … -1–infected individuals with HAART [4]. The ability of current …

… -related deaths with highly active antiretroviral therapy (HAART) is … HAART are inferior to
those in adults. This review provides an overview of the paediatric clinical studies using HAART …

… (HIV) infection owing to the high level of viral replication. Antiretroviral pressure invariably
causes the … Moreover, adherence to highly active antiretroviral therapy, not viremia, is the most …

… 1 (HIV-1) in patients on highly active antiretroviral therapy (HAART) was examined. In a
study of 22 patients successfully treated with HAART for up to 30 months, replication-competent …